Funding tied to spinal study outcomes, levels of evidence

February 28, 2014
Funding tied to spinal study outcomes, levels of evidence
Source of funding for spinal research is significantly associated with study outcome and level of evidence, according to a review published in the Feb. 1 issue of The Spine Journal.

(HealthDay)—Source of funding for spinal research is significantly associated with study outcome and level of evidence (LOE), according to a review published in the Feb. 1 issue of The Spine Journal.

Amir Reza Amiri, from the Royal National Orthopaedic Hospital in Stanmore, U.K., and colleagues conducted a systematic literature review of 1,356 published spinal studies in five leading spinal, orthopedics, neurosurgery, and general medical journals (online or print) during 2010. Information on self-reported potential conflict of interest and type of funding (foundation, industry, public, intramural, multiple [including industry], multiple [without industry], and unfunded) were identified for each paper. Oxford Center for Evidence-Based Medicine guidelines were used for LOE ranking.

The researchers observed a significant association between LOE and source of funding (P < 0.01). The greatest proportion of level IV evidence was industry-funded studies (65 percent). The proportion of industry-funded studies with favorable outcomes was significantly higher than that of publicly- and foundation-funded studies (88 percent versus 73 and 74 percent, respectively). In industry-funded studies, the associated odds ratio for reporting favorable outcomes was 2.7 compared to studies with public funding and 2.6 compared to studies with foundation funding. The highest proportions of unfavorable (14 percent) and equivocal (23 percent) outcomes were seen with level I studies, whereas level IV studies had the highest proportion of favorable outcome (85 percent). Self-reported conflict of interest was not associated with LOE (P = 0.83) or study outcome (P = 0.25).

"We demonstrated a significant association between source of funding, study outcome, and LOE in research," the authors write.

Explore further: Positive outcome no more likely in industry-funded trials

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Positive outcome no more likely in industry-funded trials

July 5, 2012
(HealthDay) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research ...

Does the timing of surgery to treat traumatic spinal cord injury affect outcomes?

October 24, 2013
Performing surgery to take pressure off the spine after a traumatic injury soon after the event could prevent or reverse some of the secondary damage caused by swelling and decreased blood flow to the injured spine. However, ...

Updated guidelines available for lumbar spinal stenosis

August 8, 2013
(HealthDay)—Updated evidence-based guidelines on the diagnosis and treatment of degenerative lumbar spinal stenosis are now available, according to report published in the July issue of The Spine Journal.

Chiropractic care beats sham therapy for spinal pain

November 19, 2013
(HealthDay)—Short-term chiropractic therapy is more effective than a sham intervention for treating spinal pain, but the difference is not clinically meaningful, according to research published in the Nov. 15 issue of Spine.

Tests don't predict outcome after spine fusion for back pain

November 15, 2012
(HealthDay)—Currently, there is no test available to reliably predict which patients with chronic low back pain (LBP) will achieve a good clinical outcome after spinal fusion surgery, according to the results of a literature ...

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.